[SHINSA]Points to Consider in the Clinical Development of Radiopharmaceuticals for Positron Emission Tomography Targeting Prostate Specific Membrane Antigen (PSMA PET) (Early Consideration) posted
Early Consideration is reference information and point of view at that time for promoting the practi...
Publisher
Japan
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalIn-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Summary excerpt
Early Consideration is reference information and point of view at that time for promoting the practi...
Source route
Continue on pmda.go.jp
Leave the platform to read the original full article on the publisher site.
Source: PMDA Japan
Scope: Regulatory
Related coverage
More related coverage
Decision: Orphan registered medicinal products
A list of authorised orphan medicinal products registered by the UK licensing authority.
Guidance: Meningitis – Patient Factsheet
Meningitis is a serious infection that can develop quickly and affect people of all ages
Correspondence: MHRA e-cigarette and vape products regulator profile
Information on the other regulatory bodies responsible for e-cigarette and vape products.
La AEMPS informa del cese de comercialización y retirada del mercado de un lote del cosmético Fresh baby sunscreen SPF 50
Generar PDF Fecha de publicación: 20 de marzo de 2026 CategorÃa: cosméticos Referencia: COS, 05/2026...